Category: Prostate Cancer

Focal therapy gives men with localized prostate cancer an appealing option—effective control with fewer side effects. Discover who qualifies for focal treatment, how it compares to radical approaches and Active Surveillance, and why specialized diagnosis is essential. keep reading

Traditional PSA screening can lead to overdetection and unnecessary biopsies due to its lack of specificity for prostate cancer. New research highlights biparametric MRI as a promising, quicker, and potentially more accurate first-line screening tool. keep reading

Dr. Eric Walser brings a unique blend of innovation, compassion, and experience to the Sperling Prostate Center. Learn how his journey from academia to advanced prostate care is making a difference for men seeking the latest in diagnosis and treatment. keep reading

Dr. Eric Walser, a leader in focal ablation for prostate cancer, is now part of the Sperling Prostate Center team. His expertise in interventional radiology and men’s health enhances advanced care and brings new treatments to the Center. keep reading

Imagine seeing even clearer prostate images than today’s advanced 3T MRI allows—5T MRI could make that a reality. While research teams report remarkable image quality and better tumor visibility with 5T, economic and practical challenges mean that 3T MRI remains the standard for prostate cancer screening and treatment guidance. keep reading

Deciding on Active Surveillance for prostate cancer isn’t always straightforward. Adding genomic testing to standard factors like PSA, MRI, and biopsy can reveal hidden risks and help ensure the safest, most personalized treatment path. keep reading

What if a computer could spot key signs of prostate cancer on MRI scans just as well as a seasoned radiologist—or even better? As thousands of new prostate MRIs need expert reading each year, artificial intelligence is stepping in with data-driven precision, promising to sharpen diagnostic accuracy and lighten the load for busy professionals. keep reading

Emerging research shows genomic classifier scores from prostate cancer biopsies may offer clues about recurrence risks following focal therapy. While not yet available for routine use, this insights could be a valuable tool in future treatment decisions. keep reading

Detecting prostate cancer early makes nearly 100% treatment success possible, often with fewer side effects. Routine PSA screening and modern imaging tools help identify cancer while it's still most curable. Skipping annual tests risks missing the critical window for best outcomes. keep reading

How can a simple blood test reveal silent cancer risks? Many men are surprised to learn early prostate cancer often shows no symptoms at all—making questions about warning signs, PSA screening, or family history even more important. Find out how age, genetics, and lifestyle shape the story, and why timing matters for peace of mind. keep reading